Earnings History Data for PDS Biotechnology Corporation (PDSB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
PDS Biotechnology Corporation
PDS Biotechnology Corp. is an immuno-oncology company. It is focused on developing a pipeline of clinical-stage immunotherapies to treat cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, cancer and other cancers. The company's products are based on the proprietary Versamune(R) platform technology, which activates and directs the human immune system. PDS Biotechnology Corp, formerly known as Edge Therapeutics Inc., is based in Berkeley Heights, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | PDSB | PDS Biotechnology Corporation | 108.99 | -0.29 | -0.29 | -0.35 | PDS Biotechnology GAAP EPS of -$0.29 misses by $0.01 [11/14/2024 8:01 AM] |
2.25 | -0.50 (-18.15%) |
2.25 | -0.50 (-18.33%) |
1.53 - 6.85 | 3,266,534 | 390,000 | 59,000 | ||
| 13-08-2024 | PM | PDSB | PDS Biotechnology | 112.00 | -0.23 | -0.31 | 0.00 | PDS Biotechnology GAAP EPS of -$0.23 beats by $0.10 [8/13/2024 8:02 AM] |
3.07 | 0.02 (0.66%) |
3.16 | 0.11 (3.61%) |
2.53 - 6.85 | 221,064 | 310,000 | 1,706 | ||
| 15-05-2024 | PM | PDSB | PDS Biotechnology Corporation | 128.74 | -0.30 | -0.37 | -0.32 | PDS Biotechnology GAAP EPS of -$0.30 beats by $0.06 [5/15/2024 8:02 AM] |
3.50 | -0.04 (-1.13%) |
3.68 | 0.15 (4.10%) |
2.59 - 10.27 | 528,254 | 840,000 | 6,209 | ||
| 27-03-2024 | PM | PDSB | PDS Biotechnology Corporation | 147.14 | -0.34 | -0.39 | -0.67 | PDS Biotechnology GAAP EPS of -$1.39 beats by $0.06 [3/27/2024 7:31 AM] |
3.86 | -0.62 (-13.84%) |
4.00 | -0.48 (-10.71%) |
3.61 - 10.27 | 3,994,959 | 830,000 | 287,896 | ||
| 14-11-2023 | PM | PDSB | PDS Biotechnology Corporation | 164.84 | -0.35 | -0.42 | -0.26 | PDS Biotechnology GAAP EPS of -$0.35 beats by $0.10 [11/14/2023 7:37 AM] |
6.22 | 0.97 (18.46%) |
5.49 | 0.24 (4.47%) |
3.80 - 13.65 | 1,196,231 | 520,000 | 20,555 | ||
| 14-08-2023 | PM | PDSB | PDS Biotechnology Corporation | 147.80 | -0.37 | -0.37 | -0.20 | PDS Biotechnology GAAP EPS of -$0.37 misses by $0.02 [8/14/2023 7:37 AM] |
5.33 | 0.48 (9.90%) |
5.15 | 0.30 (6.19%) |
2.89 - 13.65 | 749,077 | 440,000 | 10,698 | ||
| 15-05-2023 | PM | 7:30 AM ET (May 15) |
PDSB | PDS Biotechnology Corporation | 206.00 | -0.32 | -0.31 | -0.32 | PDS Biotechnology GAAP EPS of -$0.32 misses by $0.01 [5/15/2023 7:36 AM] |
6.93 | 0.48 (7.44%) |
0.0 | 0.0 (0.00%) |
2.89 - 13.65 | 311,030 | 190,000 | 0 | |
| 28-03-2023 | PM | 7:30 AM ET (Mar 28) |
PDSB | PDS Biotechnology Corporation | 229.08 | -0.67 | -0.30 | -0.23 | PDS Biotechnology GAAP EPS of -$1.43 misses by $0.35 [3/28/2023 7:34 AM] |
5.85 | 0.17 (2.99%) |
0.0 | 0.0 (0.00%) |
2.89 - 13.65 | 400,016 | 350,000 | 0 | |
| 14-11-2022 | PM | 7:00 AM ET (Nov 14) |
PDSB | PDS Biotechnology Corporation | 157.38 | -0.26 | -0.26 | -0.24 | PDS Biotechnology GAAP EPS of -$0.26 beats by $0.02 [11/14/2022 7:36 AM] |
7.03 | 1.43 (25.54%) |
6.83 | 1.23 (21.96%) |
2.89 - 11.57 | 14,452,786 | 270,000 | 2,990,403 | |
|
||||||||||||||||||
| 08-08-2022 | PM | 7:00 AM ET (Aug 8) |
PDSB | PDS Biotechnology Corporation | 114.66 | -0.20 | -0.30 | -0.22 | PDS Biotechnology GAAP EPS of -$0.20 beats by $0.08 [8/8/2022 7:13 AM] |
5.20 | -0.11 (-2.07%) |
5.33 | 0.02 (0.38%) |
2.91 - 17.85 | 391,226 | 270,000 | 7,694 | |
| 11-05-2022 | PM | 7:00 AM ET (May 11) |
PDSB | PDS Biotechnology Corporation | 131.44 | -0.32 | -0.23 | -0.14 | PDS Biotechnology GAAP EPS of -$0.32 misses by $0.09 [5/11/2022 7:08 AM] |
3.76 | -0.71 (-15.97%) |
4.35 | -0.12 (-2.68%) |
3.65 - 17.85 | 773,462 | 280,000 | 5,428 | |
| 31-03-2022 | PM | 7:00 AM ET (Mar 31) |
PDSB | PDS Biotechnology Corporation | 172.05 | -0.23 | -0.23 | -0.16 | PDS Biotechnology GAAP EPS of -$0.66 beats by $0.05 [3/31/2022 7:06 AM] |
6.17 | -0.12 (-1.91%) |
6.29 | 0.0 (0.00%) |
4.10 - 17.85 | 327,481 | 210,000 | 427 | |
| 10-11-2021 | PM | 7:05 AM ET (Nov 10) |
PDSB | PDS Biotechnology Corporation | 326.59 | -0.24 | -0.22 | -0.23 | PDS Biotechnology EPS misses by $0.04 [11/10/2021 7:17 AM] |
10.21 | -0.46 (-4.31%) |
10.53 | -0.14 (-1.31%) |
1.92 - 17.85 | 764,655 | 350,000 | 7,606 | |
| 12-08-2021 | PM | 7:00 AM ET (Aug 12) |
PDSB | PDS Biotechnology Corporation | 308.06 | -0.22 | -0.20 | -0.19 | PDS Biotechnology EPS beats by $0.13 [8/12/2021 7:18 AM] |
10.89 | 0.30 (2.83%) |
10.66 | 0.07 (0.66%) |
1.84 - 13.48 | 503,338 | 350,000 | 7,396 | |
| 13-05-2021 | PM | 7:00 AM ET (May 13) |
PDSB | PDS Biotechnology Corporation | 103.82 | -0.14 | -0.20 | -0.39 | PDS Biotechnology EPS beats by $0.05 [5/13/2021 7:07 AM] |
4.48 | 0.08 (1.82%) |
4.72 | 0.32 (7.27%) |
0.82 - 7.30 | 429,743 | 600,000 | 6,864 | |
|
||||||||||||||||||
| 18-03-2021 | PM | 6:00 AM ET (Mar 18) |
PDSB | PDS Biotechnology Corporation | 121.55 | -0.16 | -0.18 | -0.52 | PDS Biotechnology EPS misses by $0.06 [3/18/2021 7:07 AM] |
4.91 | -0.36 (-6.83%) |
5.40 | 0.13 (2.47%) |
0.62 - 7.30 | 862,495 | 5,330,000 | 28,056 | |
|
||||||||||||||||||
| 11-11-2020 | AH | PDSB | PDS Biotechnology Corporation | 45.41 | -0.23 | -0.27 | -1.10 | PDS Biotechnology reports Q3 results [11/11/2020 4:07 PM] |
2.08 | -0.14 (-6.50%) |
2.18 | -0.05 (-2.24%) |
0.62 - 4.98 | 256,273 | 631,417 | 1,754 | ||
|
|
||||||||||||||||||
| 13-08-2020 | PM | 6:00 AM ET (Aug 13) |
PDSB | PDS Biotechnology Corporation | 46.08 | -0.19 | -0.26 | -0.75 | 2.88 | -0.06 (-2.04%) |
2.98 | 0.04 (1.36%) |
0.62 - 6.50 | 736,996 | 1,694,598 | 50,023 | ||
|
|
||||||||||||||||||
| 13-05-2020 | PM | 6:00 AM ET (May 13) |
PDSB | PDS Biotechnology Corporation | 14.49 | -0.39 | -0.15 | -1.07 | 0.8732 | -0.04 (-3.87%) |
0.92 | 0.05 (5.36%) |
0.62 - 9.45 | 219,328 | 283,076 | 2,000 | ||
|
|
||||||||||||||||||